Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof

A complex, joint cavity technology, applied in the field of non-viral nano-nucleic acid transport complex and its preparation, can solve the problems of large molecular weight, limited application, high solution viscosity, etc., to increase water solubility, reduce viscosity, and enhance biocompatibility sexual effect

Inactive Publication Date: 2007-12-12
NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, the molecular weight of undegraded high molecular weight chitosan (High Molecular Weight Chitosan, HMWC) is too large, it is difficult to dissolve in water, and needs to be dis...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof
  • Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof
  • Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The preparation of embodiment 1 low molecular weight chitosan

[0054]Get 5g commercially available high molecular weight chitosan (St.Louis, MO, USA, molecular weight is about 150KDa, 85% deacetylation) in the 250ml round bottom flask, add the 4M HCl of 125ml, 100 ℃ of oil baths 15 hours, simultaneously Stir. After cooling, filter with double-layer lens-cleaning paper to obtain 85ml of solution, add an equal volume of absolute ethanol to the solution, mix well, and freeze overnight at 4°C. Then centrifuge at 10000rpm for 10 minutes and discard the supernatant. Add 50ml of 50% ethanol to the pellet to wash, resuspend, and centrifuge at 10000rpm for 10 minutes. Repeat the above washing, suspension and centrifugation process three times. The precipitate was dried, dissolved in 15 ml of double distilled water, and finally freeze-dried to obtain a white powdery solid, which was low molecular weight chitosan. The composition of the product was determined by elemental ana...

Embodiment 2

[0055] The preparation of embodiment 2 low molecular weight chitosan

[0056] Get 5g commercially available high molecular weight chitosan (St.Louis, MO, USA, molecular weight is about 150KDa, 85% deacetylation) in the 250ml round bottom flask, add the 4M HCl of 140ml, 100 ℃ of oil baths 25 hours, simultaneously Stir. After cooling, filter with double-layer lens-cleaning paper to obtain 90 ml of solution, add an equal volume of absolute ethanol to the solution, mix well, and freeze overnight at 4°C. Then centrifuge at 10000rpm for 10 minutes and discard the supernatant. Add 50ml of 50% ethanol to the pellet to wash, resuspend, and centrifuge at 10000rpm for 10 minutes. Repeat the above washing, suspension and centrifugation process three times. The precipitate was dried, dissolved in 15 ml of double distilled water, and finally freeze-dried to obtain a white powdery solid, which was low molecular weight chitosan. The composition of the product was determined by elemental a...

Embodiment 3

[0057] The preparation of embodiment 3 low molecular weight chitosan

[0058] Get 5g commercially available high molecular weight chitosan (St.Louis, MO, USA, molecular weight is about 150KDa, 85% deacetylation) in the 250ml round bottom flask, add the 4M HCl of 110ml, 100 ℃ of oil baths 10 hours, simultaneously Stir. After cooling, filter with double-layer lens-cleaning paper to obtain 90 ml of solution, add an equal volume of absolute ethanol to the solution, mix well, and freeze overnight at 4°C. Then centrifuge at 10000rpm for 10 minutes and discard the supernatant. Add 50ml of 50% ethanol to the pellet to wash, resuspend, and centrifuge at 10000rpm for 10 minutes. Repeat the above washing, suspension and centrifugation process three times. The precipitate was dried, dissolved in 15 ml of double distilled water, and finally freeze-dried to obtain a white powdery solid, which was low molecular weight chitosan. The composition of the product was determined by elemental a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Diameteraaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a non-viral nanometer nucleic acid transportation compound used for treating cartilage defect through intra-articular injection which comprises low-molecular chitosan with molecular weight of 5KD-100KDand percentage composition of amino group of 30-70%, and nucleic acid, wherein N/P of the compound is 0.2:1-10:1.The invention degrades high molecular chitosan to low molecular chitosan, increases water solubility of material, reduces viscosity of solution, reduces influence of sour environment of solvent to cell, improves compound size with nanometer, is in favor of performing genetic transmission to cartilago articularis cell, and protects target nucleic acid from neutralizing with synovial fluid and being degrade by nuclease in lysosome. The invention has simple preparation and abroad application scope; can solve engineering roadblock of cartilage repair with no requirement of operation, complex device and bracket material.

Description

technical field [0001] The invention belongs to the technical field of biopharmaceuticals, and in particular relates to a non-viral nano-nucleic acid transport complex used for intra-articular injection to treat cartilage defects and a preparation method thereof. Background technique [0002] Articular cartilage defect is one of the common and difficult clinical diseases, which can be caused by trauma, inflammation, tumor and autoimmune diseases and other reasons. After the defect occurs, it is difficult to repair. This is because the articular cartilage is hyaline cartilage, which has a special structure different from other cartilages. It is mainly composed of chondrocytes embedded in the lacuna of the cartilage matrix, and is a single connective tissue. The cartilage matrix is ​​mainly synthesized and maintained by chondrocytes, and its main components are various proteoglycans and collagen fibers mainly composed of type II collagen. Articular cartilage tissue has neithe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/36A61K48/00A61P19/08
Inventor 赵建宁王瑞郭亭张峻峰
Owner NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap